Getinge

Getinge takes a leap forward in cardiovascular surgery with the 510(k) clearance for Vasoview Hemopro 3

Retrieved on: 
Friday, March 8, 2024

Designed with customer centricity top of mind, the newcomer is expected to offer enhanced procedural efficiency in healthcare from the upcoming launch.

Key Points: 
  • Designed with customer centricity top of mind, the newcomer is expected to offer enhanced procedural efficiency in healthcare from the upcoming launch.
  • Receiving the FDA 510(k) clearance for Vasoview Hemopro 3 marks a significant milestone for Getinge and underscores the effort to comply with the highest safety and effectiveness standards, emphasizing the medtech company's commitment to advancing medtech.
  • The new generation of Vasoview – Hemopro 3 – symbolizes our dedication to elevating healthcare standards together with our customers," says Elin Frostehav, President Acute Care Therapies at Getinge.
  • The culmination of extensive market research and advisory boards conducted in partnership with clinicians within the EVH field, Vasoview Hemopro 3 represents collaborative innovation.

Ericsson appoints Lars Sandström as Chief Financial Officer

Retrieved on: 
Tuesday, January 23, 2024

Effective as of April 1, 2024

Key Points: 
  • Effective as of April 1, 2024
    Member of Ericsson's Executive Team, reporting to the CEO
    STOCKHOLM, Jan. 23, 2024 /PRNewswire/ -- Ericsson (NASDAQ: ERIC) today announces the appointment of Lars Sandström as its new Chief Financial Officer, Senior Vice President, and Head of Group Function Finance.
  • Lars Sandström is currently Chief Financial Officer and member of the executive team at Getinge - a listed global leader within Medtech.
  • Börje Ekholm, President and CEO of Ericsson, said: "I warmly welcome Lars Sandström to Ericsson.
  • Commenting on the appointment, Mr. Sandström says: "I'm very excited to join Ericsson and to help drive the creation of game-changing technologies and services that shape our future.

Ericsson appoints Lars Sandström as Chief Financial Officer

Retrieved on: 
Tuesday, January 23, 2024

Effective as of April 1, 2024

Key Points: 
  • Effective as of April 1, 2024
    Member of Ericsson's Executive Team, reporting to the CEO
    STOCKHOLM, Jan. 23, 2024 /PRNewswire/ -- Ericsson (NASDAQ: ERIC) today announces the appointment of Lars Sandström as its new Chief Financial Officer, Senior Vice President, and Head of Group Function Finance.
  • Mr. Sandström will join Ericsson on April 1, 2024, and will be based in Sweden.
  • Lars Sandström is currently Chief Financial Officer and member of the executive team at Getinge - a listed global leader within Medtech.
  • Börje Ekholm, President and CEO of Ericsson, said: "I warmly welcome Lars Sandström to Ericsson.

United Medical Device Cleaning & Recycling Market Insights, 2022-2023 & 2028 Featuring Key Vendors - Steris, Getinge, ECOLAB, 3M, and Stryker - ResearchAndMarkets.com

Retrieved on: 
Friday, September 29, 2023

In the US, the medical device cleaning & recycling market was valued at $3.52 billion in 2022 and is expected to grow at a CAGR of 11.47% from 2022-2028.

Key Points: 
  • In the US, the medical device cleaning & recycling market was valued at $3.52 billion in 2022 and is expected to grow at a CAGR of 11.47% from 2022-2028.
  • This report provides valuable insights into the US medical device cleaning and recycling market, offering market size and forecast data.
  • Leading players in the medical device cleaning and recycling market include Steris, Getinge, ECOLAB, 3M, and Stryker.
  • This report provides a comprehensive and current market scenario of the US medical device cleaning & recycling market, including the US medical device cleaning & recycling market size, anticipated market forecast, relevant market segmentations, and industry trends.

Getinge recieves US FDA 510(k) clearance for Servo-air® Lite

Retrieved on: 
Friday, July 7, 2023

GOTHENBURG, Sweden, July 7, 2023 /PRNewswire/ -- "We are happy to broaden our ventilator product offering for the US market", says Elin Frostehav, President Acute Care Therapies at Getinge. "This significantly increases our addressable ventilation market in the US, by now being able to target the non-invasive hospital segment with our ventilation offering." 

Key Points: 
  • Getinge announces clearance from the US FDA for Servo-air® Lite, a wall gas independent non-invasive mechanical ventilator.
  • GOTHENBURG, Sweden, July 7, 2023 /PRNewswire/ -- "We are happy to broaden our ventilator product offering for the US market", says Elin Frostehav, President Acute Care Therapies at Getinge.
  • "This significantly increases our addressable ventilation market in the US, by now being able to target the non-invasive hospital segment with our ventilation offering."
  • Servo-air® Lite is Getinge's turbine-driven ventilator for non-invasive ventilation.

Getinge Selects Anaqua to Provide Single, Centralized IP Management Platform

Retrieved on: 
Tuesday, June 6, 2023

BOSTON, June 06, 2023 (GLOBE NEWSWIRE) -- Anaqua, the leading innovation and intellectual property (IP) management technology provider, today announced that global medical technology company Getinge has selected Anaqua’s AQX in order to consolidate the management of all its IP assets onto a single, centralized platform.

Key Points: 
  • BOSTON, June 06, 2023 (GLOBE NEWSWIRE) -- Anaqua , the leading innovation and intellectual property (IP) management technology provider, today announced that global medical technology company Getinge has selected Anaqua’s AQX in order to consolidate the management of all its IP assets onto a single, centralized platform.
  • Founded in Sweden in 1904, Getinge provides hospitals and life science institutions in 133 countries with products and solutions that aim to improve clinical results and optimize workflows.
  • We are delighted to be supporting Getinge on that journey by helping manage and protect the company’s valuable IP assets.
  • Anaqua continues to invest in offerings to meet and exceed the ever-evolving demands of the world’s most innovative life science companies.”

Operating Room Integration Market worth $3.7 billion | MarketsandMarkets

Retrieved on: 
Thursday, June 1, 2023

Operating Room Integration Market Advantages:

Key Points: 
  • Operating Room Integration Market Advantages:
    Improved Efficiency: Operating room integration systems streamline workflow and enhance efficiency by integrating various devices, equipment, and information systems into a unified platform.
  • Advanced Surgical Capabilities: Operating room integration systems facilitate the integration of advanced technologies such as robotic-assisted surgery, intraoperative imaging, and navigation systems.
  • Operating Room Integration market - Report Highlights:
    The global operating room integration in healthcare market is projected to reach USD 3,673.2 million by 2028 from USD 2,071.7 million in 2023, at a high CAGR of 12.1% during the forecast period.
  • Market Overview: This edition includes updated market dynamics and market ecosystems specific to the operating room integration market.

Operating Room Integration Market worth $3.7 billion | MarketsandMarkets

Retrieved on: 
Thursday, June 1, 2023

Operating Room Integration Market Advantages:

Key Points: 
  • Operating Room Integration Market Advantages:
    Improved Efficiency: Operating room integration systems streamline workflow and enhance efficiency by integrating various devices, equipment, and information systems into a unified platform.
  • Advanced Surgical Capabilities: Operating room integration systems facilitate the integration of advanced technologies such as robotic-assisted surgery, intraoperative imaging, and navigation systems.
  • Operating Room Integration market - Report Highlights:
    The global operating room integration in healthcare market is projected to reach USD 3,673.2 million by 2028 from USD 2,071.7 million in 2023, at a high CAGR of 12.1% during the forecast period.
  • Market Overview: This edition includes updated market dynamics and market ecosystems specific to the operating room integration market.

National Business Research Institute Recognizes Getinge with Circle of Excellence Award

Retrieved on: 
Thursday, April 27, 2023

WAYNE, N.J., April 27, 2023 /PRNewswire/ -- Getinge announced today that the National Business Research Institute (NBRI) recognized Getinge Care Technical Services with the NBRI Circle of Excellence Award. This is the third year that Getinge has won this prestigious award. The NBRI Circle of Excellence Award recognizes organizations that demonstrate high levels of customer experience through the rigorous, scientific, psychological research of their customers. Organizations must score at or above Stretch Performance at the 75th percentile of their industry.

Key Points: 
  • WAYNE, N.J., April 27, 2023 /PRNewswire/ -- Getinge announced today that the National Business Research Institute (NBRI) recognized Getinge Care Technical Services with the NBRI Circle of Excellence Award.
  • This is the third year that Getinge has won this prestigious award.
  • The NBRI Circle of Excellence Award recognizes organizations that demonstrate high levels of customer experience through the rigorous, scientific, psychological research of their customers.
  • "Getinge's high achievement of earning this prestigious award is a direct result of Getinge's dedication to measuring and improving their customer experience."

Getinge recieves FDA premarket approval for the iCast™ covered stent system in the US

Retrieved on: 
Friday, March 24, 2023

GOTHENBURG, Sweden, March 24, 2023 /PRNewswire/ -- Getinge's iCast™ covered stent system has received premarket approval from the U.S. Food and Drug Administration (FDA) for the treatment of patients with iliac arterial occlusive disease.

Key Points: 
  • GOTHENBURG, Sweden, March 24, 2023 /PRNewswire/ -- Getinge's iCast™ covered stent system has received premarket approval from the U.S. Food and Drug Administration (FDA) for the treatment of patients with iliac arterial occlusive disease.
  • "We are pleased that the iCast™ stent system is approved in the United States for use in iliac arteries to benefit an even greater number of patients", says Elin Frostehav, President Acute Care Therapies at Getinge.
  • Getinge will continue to ramp up capacity throughout the year in order to meet the demand."
  • The iCast covered stent system, which is sold outside the US under the brand name Advanta V12 covered stent, has been used by clinicians for 20 years and is the most clinically evaluated balloon expandable polytetrafluoroethylene (ePTFE)-covered stent in the world, with clinical data published in more than 550 articles.